Headwinds for the Russian ruble and Turkish lira held back growth at Recordati's OTC business in the first quarter of 2024.
A strong quarter for cough and cold products was held back by unfavorable exchange rates leaving Recordati Industria Chimica & Farmaceutica SPA’s OTC sales slightly down in the opening three months of 2024.
The Milan, Italy-based company reported OTC turnover 0.2% lower at €95.3m ($104m) in the first quarter as it felt the...
“Harnessing AI’s astounding abilities to improve people’s lives and relieve overburdened healthcare systems is one of the great opportunities of our time,” argues Stada CEO Peter Goldschmidt in the company's Health Report 2025.
Creating a working group to drive Rx-to-OTC switch is one of the ways in which Finland could expand self-care and save €60m per year for the country's health system, suggests a recently published report commissioned by Haleon.
Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.
Pharma Deutschland is one of 21 German associations calling for trilogue negotiations in relation to the EU Green Claims Directive to be suspended while a “comprehensive and independent written impact assessment” is undertaken.
HBW Insight catches up with sustainability expert Jasper Crone to find out what consumer health companies need to know about the European Commission's Omnibus simplification package.
The European OTC market grew at double the rate of the global market in the last twelve months, according to IQVIA Consumer Health, driven by a long-term trend for prevention. Consultancy Simon Kucher identifies a desire to live a longer, healthier life as the primary concern behind this trend.
Limited capacity and a two-to-three year timescale for reformulation could mean that many VMS supplements disappear from the market, warns EPPA partner Alexandra Bocquillion, speaking at the AESGP Annual Meeting in Warsaw, Poland.
